As the administrative and economic heart of the country, Mexico City (CDMX) is witnessing a paradigm shift in pharmaceutical manufacturing. With the rise of "Nearshoring," global pharmaceutical entities are looking at the Valle de México not just as a consumer market, but as a strategic production hub for the Americas. The local industrial landscape, particularly in areas like Xochimilco and Tlalpan, is home to sophisticated manufacturing clusters that demand high-purity APIs and complex intermediates.
Jiangxi Serum Pharma Industries Co., Ltd. recognizes the unique logistical and regulatory requirements of Mexico City. From navigating the COFEPRIS (Comisión Federal para la Protección contra Riesgos Sanitarios) certification pathways to ensuring cold-chain integrity for biological products, we act as a bridge between advanced Chinese chemical synthesis and the burgeoning Mexican healthcare sector.
Years Experience
Annual Sales
Global Clients
Supply Partners
We are shifting away from traditional petrochemical synthesis toward enzymatic catalysis and microbial fermentation. This reduces carbon footprints—a critical metric for Mexican companies aiming for ESG compliance.
Optimizing the bioavailability of poorly soluble APIs. Our co-crystallization services allow Mexico City manufacturers to enhance drug efficacy without altering the molecular structure of the API itself.
Utilizing machine learning to predict reaction yields and impurity profiles, ensuring that the intermediates supplied to Mexico City are of the highest consistent purity (99.9%+).
Jiangxi Serum Pharma Industries Co., Ltd. is a professional supplier of pharmaceutical and nutritional products in China. For nearly 10 years, we have been dedicated to exporting biological products, vaccines, Western medicines, raw materials, intermediates, medical consumables, food additives, and plant extracts, and have accumulated rich industry experience.
Established in 2017, we have built a network of over 200 close-related suppliers, enabling us to provide a comprehensive range of solutions for the modern pharmaceutical enterprise.
Connect With Our Experts
Procuring APIs and Intermediates for Mexico City involves more than just price negotiation. It requires a deep understanding of Regulatory Harmonization. Our team provides comprehensive documentation support, including:
By addressing these "hidden" procurement hurdles, we reduce the time-to-market for Mexican pharmaceutical labs by up to 30%, providing a definitive Information Gain in your supply chain strategy.
Analysis of the shift from shark-based to plant-based squalene for high-end topical formulations and vaccine adjuvants in the LATAM region.
Learn moreWhy this critical molecule remains a cornerstone for modern medicine and its rising demand in Mexican hospital systems.
Learn moreExploring the fastest FDA approval of orforglipron and its implications for the metabolic health market in Mexico City.
Learn moreConnect with a partner who understands the chemistry, the regulations, and the local nuances of Mexico City.
Send Inquiry Now
